Primary sclerosing cholangitis: Current and future management strategies

John E. Eaton, Jayant A. Talwalkar

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease. The etiology of this disorder is unknown and there are no effective medical therapies. PSC is associated with inflammatory bowel disease and an increased risk for hepatobiliary and colorectal malignancies. The aim of this review is to highlight the clinical features and diagnostic approach to patients with suspected PSC, characterize associated comorbidities, review screening strategies for PSC associated malignancies and review contemporary and future therapies.

Original languageEnglish (US)
Pages (from-to)28-36
Number of pages9
JournalCurrent Hepatitis Reports
Volume12
Issue number1
DOIs
StatePublished - Mar 2013

Fingerprint

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Comorbidity
Liver Diseases
Neoplasms
Therapeutics

Keywords

  • Diagnosis
  • Management
  • Primary sclerosing cholangitis

ASJC Scopus subject areas

  • Hepatology
  • Virology

Cite this

Primary sclerosing cholangitis : Current and future management strategies. / Eaton, John E.; Talwalkar, Jayant A.

In: Current Hepatitis Reports, Vol. 12, No. 1, 03.2013, p. 28-36.

Research output: Contribution to journalArticle

Eaton, John E. ; Talwalkar, Jayant A. / Primary sclerosing cholangitis : Current and future management strategies. In: Current Hepatitis Reports. 2013 ; Vol. 12, No. 1. pp. 28-36.
@article{ff4aa05471d443c4babb4968b5a987ae,
title = "Primary sclerosing cholangitis: Current and future management strategies",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease. The etiology of this disorder is unknown and there are no effective medical therapies. PSC is associated with inflammatory bowel disease and an increased risk for hepatobiliary and colorectal malignancies. The aim of this review is to highlight the clinical features and diagnostic approach to patients with suspected PSC, characterize associated comorbidities, review screening strategies for PSC associated malignancies and review contemporary and future therapies.",
keywords = "Diagnosis, Management, Primary sclerosing cholangitis",
author = "Eaton, {John E.} and Talwalkar, {Jayant A.}",
year = "2013",
month = "3",
doi = "10.1007/s11901-012-0155-1",
language = "English (US)",
volume = "12",
pages = "28--36",
journal = "Current Hepatitis Reports",
issn = "1540-3416",
publisher = "Springer Publishing Company",
number = "1",

}

TY - JOUR

T1 - Primary sclerosing cholangitis

T2 - Current and future management strategies

AU - Eaton, John E.

AU - Talwalkar, Jayant A.

PY - 2013/3

Y1 - 2013/3

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease. The etiology of this disorder is unknown and there are no effective medical therapies. PSC is associated with inflammatory bowel disease and an increased risk for hepatobiliary and colorectal malignancies. The aim of this review is to highlight the clinical features and diagnostic approach to patients with suspected PSC, characterize associated comorbidities, review screening strategies for PSC associated malignancies and review contemporary and future therapies.

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease. The etiology of this disorder is unknown and there are no effective medical therapies. PSC is associated with inflammatory bowel disease and an increased risk for hepatobiliary and colorectal malignancies. The aim of this review is to highlight the clinical features and diagnostic approach to patients with suspected PSC, characterize associated comorbidities, review screening strategies for PSC associated malignancies and review contemporary and future therapies.

KW - Diagnosis

KW - Management

KW - Primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=84877574962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877574962&partnerID=8YFLogxK

U2 - 10.1007/s11901-012-0155-1

DO - 10.1007/s11901-012-0155-1

M3 - Article

AN - SCOPUS:84877574962

VL - 12

SP - 28

EP - 36

JO - Current Hepatitis Reports

JF - Current Hepatitis Reports

SN - 1540-3416

IS - 1

ER -